Pew Prescription Project

More than $12 billion is spent each year in the United States to market directly to doctors new medicines and medical devices. Although many of these new treatments improve the lives of patients, aggressive marketing is also creating real and perceived conflicts of interest. Research has shown that medical decision-making based on marketing rather than independent scientific evidence can compromise patient care, increase health care costs and erode public confidence in the medical profession.

The Prescription Project seeks to promote policies that eliminate conflicts of interest at academic medical centers, within professional medical societies and among public and private payers.  

The project builds upon recommendations for reforms at academic medical centers outlined in a January 2006 Journal of the American Medical Association article written by leading medical and academic experts.

For more information, visit the Prescription Project Web site.

Report

Related Content

Press Release

Media Coverage

E-Alerts & Newsletter

Stay updated with Pew News Now! We invite you to sign up to receive our weekly e-mail newsletter.

Heparin

"After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs" provides an overview of today's complex pharmaceutical supply chain and advances proposed policy solutions to help reduce the risks of counterfeit, adulterated and substandard drugs.

Read More

After-Heparin-Report-Cover

X
(All Fields are required)